Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -1489.99% is 14% below its 2-year average of -1304.58%, near the high end of its 2-year range (-4876.63%–-214.84%).
As of the fiscal period ended Tuesday, June 30, 2026. 138.77% below its 12-month average of -624.03%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -1489.99%.
RETURN ON INVESTED CAPITAL (ROIC)
-1489.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-624.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-138.77%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.19%
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-5379.92%
vs the sector median at left
Actuate Therapeutics Inc
Market Cap
$20.93M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-624.03%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$21.90M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$18.82M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$18.77M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
Market Cap
$24.44M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$16.58M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.54M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$25.48M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-80.89%
3Y Avg
-129.43%
5Y Avg
-113.96%
Market Cap
$16.22M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $20.93M | -1489.99% | -624.03% | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -14.21% | -12.54% | -12.42% | -37.50% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -46.69% | -40.71% | -34.73% | -24.39% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -171.06% | -106.73% | -106.73% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -146.30% | -66.51% | -47.74% | -43.26% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -85.72% | -120.02% | -101.35% | -83.66% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -279.48% | -96.52% | -105.30% | -89.17% |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -53.34% | -80.89% | -129.43% | -113.96% |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -273.70% | -707.06% | -535.27% | -358.40% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -41.81% | -159.62% | -298.97% | -203.41% |
ROIC
-1490.0%
ROE
-2067.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -1489.99% |
| 2026-03-31 | -521.19% |
| 2025-12-31 | -270.07% |
| 2025-09-30 | -214.84% |
| 2024-12-31 | -4876.63% |
| 2024-09-30 | -454.73% |
